Patents by Inventor Alex P. Scopton

Alex P. Scopton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11066370
    Abstract: The present invention relates to a compound having the structure of formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where X, Y, Z, R, R1, R2, R3, R4, R5, and R6 are as described herein. The present invention also relates to compositions containing the compound having the structure of formula (I), and a method of treating cancer in a subject.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: July 20, 2021
    Assignee: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Arvin C. Dar, Ross L. Cagan, Alex P. Scopton, Masahiro Sonoshita
  • Publication number: 20200325103
    Abstract: The present invention relates to a compound having the structure of formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where X, Y, Z, R, R1, R2, R3, R4, R5, and R6 are as described herein. The present invention also relates to compositions containing the compound having the structure of formula (I), and a method of treating cancer in a subject.
    Type: Application
    Filed: November 14, 2019
    Publication date: October 15, 2020
    Inventors: Arvin C. DAR, Ross L. CAGAN, Alex P. SCOPTON, Masahiro SONOSHITA
  • Patent number: 10548897
    Abstract: This invention relates to antagonists of Kinase Suppressor of Ras (KSR). Pharmaceutical compositions comprising KSR inhibitors and methods of treating cancer are also provided.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: February 4, 2020
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Arvin Dar, Neil Dhawan, Alex P. Scopton
  • Patent number: 10519113
    Abstract: The present invention relates to a compound having the structure of formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where X, Y, Z, R, R1, R2, R3, R4, R5, and R6 are as described herein. The present invention also relates to compositions containing the compound having the structure of formula (I), and a method of treating cancer in a subject.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: December 31, 2019
    Assignee: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Arvin C. Dar, Ross L. Cagan, Alex P. Scopton, Masahiro Sonoshita
  • Publication number: 20190202789
    Abstract: The present invention relates to a compound having the structure of formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where X, Y, Z, R, R1, R2, R3, R4, R5, and R6 are as described herein. The present invention also relates to compositions containing the compound having the structure of formula (I), and a method of treating cancer in a subject.
    Type: Application
    Filed: August 17, 2017
    Publication date: July 4, 2019
    Applicant: Ichan School of Medicine at Mount Sinal
    Inventors: Arvin C. DAR, Ross L. CAGAN, Alex P. SCOPTON, Masahiro SONOSHITA
  • Publication number: 20180256577
    Abstract: This invention relates to antagonists of Kinase Suppressor of Ras (KSR). Pharmaceutical compositions comprising KSR inhibitors and methods of treating cancer are also provided.
    Type: Application
    Filed: April 15, 2016
    Publication date: September 13, 2018
    Inventors: Arvin Dar, Neil Dhawan, Alex P. Scopton